Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Price:
999 999.9999 JPY
Market Closed
Updated:
May 14, 2024
Taisho Pharmaceutical Holdings Co Ltd
Cost of Revenue
|
Taisho Pharmaceutical Holdings Co Ltd
Cost of Revenue Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
Cost of Revenue
-¥137.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-2%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cost of Revenue
-¥1.4T
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cost of Revenue
-¥416.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cost of Revenue
-¥626.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cost of Revenue
-¥413.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cost of Revenue
-¥350.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
See Also
What is Taisho Pharmaceutical Holdings Co Ltd's Cost of Revenue?
Cost of Revenue
-137.2B
JPY
-137.2B
JPY
Based on the financial report for Dec 31, 2023, Taisho Pharmaceutical Holdings Co Ltd's Cost of Revenue amounts to -137.2B JPY.
What is Taisho Pharmaceutical Holdings Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
-2%
Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Taisho Pharmaceutical Holdings Co Ltd have been -8% over the past three years , -8% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
